Influence
June 10, 2025

Screening for Syphilis Infection During Pregnancy: US Preventive Services Task Force Reaffirmation Recommendation Statement

Sarah Wiehe, MD

Published in JAMA. Here is a link to the article.

Regenstrief Institute authors: Sarah Wiehe, MD, MPH

The U.S. Preventive Services Task Force (USPSTF) has reaffirmed its recommendation for early, universal screening for syphilis infection in all pregnant individuals, regardless of risk factors. This reaffirmation is based on strong evidence that screening during pregnancy provides substantial net benefit in preventing congenital syphilis and its associated adverse outcomes.

Congenital syphilis is a serious and preventable condition that can lead to stillbirth, neonatal death, and severe infant complications such as bone deformities, neurological damage, and organ enlargement. In 2023, the United States recorded 3,882 cases of congenital syphilis, including 279 stillbirths and infant deaths—marking the highest rate in over three decades.

The USPSTF recommends syphilis screening as early as possible in pregnancy and, if missed, at the first opportunity thereafter. The screening process involves both treponemal and nontreponemal blood tests to enhance diagnostic accuracy. The standard treatment remains parenteral penicillin G, with desensitization protocols advised for those with allergies.

While minor harms such as false positives and medication reactions are possible, they are outweighed by the benefits of early detection and treatment. The Task Force acknowledges the lack of new evidence supporting additional screening later in pregnancy but emphasizes the need for more research in this area, particularly given racial and ethnic disparities in congenital syphilis rates.

This recommendation aligns with guidance from the CDC, ACOG, WPSI, and AAP, and underscores the critical importance of prenatal care in reducing preventable infant morbidity and mortality. The USPSTF remains committed to evidence-based recommendations that promote maternal and child health nationwide.

Authors:

US Preventive Services Task Force; Michael Silverstein1, John B Wong2, Esa M Davis3, David Chelmow4, Tumaini Rucker Coker5, Alicia Fernandez6, Ericka Gibson7, Carlos Roberto Jaén8, Marie Krousel-Wood9, Sei Lee6, Wanda K Nicholson10, Goutham Rao11, John M Ruiz12, James Stevermer13, Joel Tsevat8, Sandra Millon Underwood14, Sarah Wiehe15

Affiliations

1Brown University, Providence, Rhode Island.

2Tufts University School of Medicine, Boston, Massachusetts.

3University of Maryland School of Medicine, Baltimore.

4Virginia Commonwealth University School of Medicine, Richmond.

5University of Washington, Seattle.

6University of California, San Francisco.

7Kaiser Permanente, Atlanta, Georgia.

8The University of Texas Health Science Center, San Antonio.

9Tulane University, New Orleans, Louisiana.

10George Washington University, Washington, DC.

11Case Western Reserve University, Cleveland, Ohio.

12University of Arizona, Tucson.

13University of Missouri, Columbia.

14University of Wisconsin, Milwaukee.

15Indiana University, Bloomington.

Partners

Related News

Ontology 2.0 deepens LOINC®-SNOMED collaboration, speeds global lab interoperability

Ontology 2.0 deepens LOINC®-SNOMED collaboration, speeds global lab interoperability

INDIANAPOLIS, US and LONDON, UK – Regenstrief Institute and SNOMED International have released LOINC® Ontology 2.0, the next version

Kurt Kroenke, M.D., and Paul Musey, M.D., M.S.

Treating anxiety could curb unnecessary ED visits for low-risk chest pain

Chest pain ranks as the second most common reason for emergency department (ED) visits, making it a key concern

Dr. Rachel Patzer, Dr. Virginia Caine, Claire Fiddian-Green and Phaedra Schaffer-Corso

Regenstrief leaders join 2025 Leadership Exchange delegation in Washington, D.C.

Regenstrief Institute President and Chief Executive Officer Rachel Patzer, PhD, MPH, was part of a contingent of more than